Page last updated: 2024-12-05

molybdenum disulfide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID14823
CHEBI ID30704
MeSH IDM0220893

Synonyms (68)

Synonym
unii-zc8b4p503v
zc8b4p503v ,
[mos2]
disulfidomolybdenum
molybdenum disulphide
1317-33-5
molybdenum(iv) sulfide
mos2
molybdenum disulfide
CHEBI:30704
moly powder b
einecs 215-172-4
molykote z
m 5 (lubricant)
einecs 215-263-9
liqui-moly lm 11
molykote
sumipowder pa
molybdenite
nichimoly c
hsdb 1660
molykote microsize powder
dm 1 (sulfide)
dag 206
molycolloid cf 626
moly powder pa
t-powder
dag 325
moly powder ps
liqui-moly lm 2
mopol m
c.i. 77770
molysulfide
molybdenite (mos2)
mopol s
md 40 (lubricant)
lm 13 (lubricant)
natural molybdenite
solvest 390a
molybdenum sulfide (mos2)
moly powder c
lm 13
molybdenum ores, molybdenite
motimol
molyke r
molybdenum bisulfide
md 40
dag-v 657
molybdenum(iv) sulfide, powder, <2 mum, 99%
molybdenum(iv) sulfide, powder
bis(sulfanylidene)molybdenum
1309-56-4
FT-0628966
AKOS015903590
molybdenum disulfide [mi]
molybdenum disulfide [hsdb]
mfcd00003470
molybdenum(iv) sulfide, nanopowder, 90 nm diameter (aps), 99% trace metals basis
molybdenum disulfide, crystal, 99.995%
henderson molybdenite, nist rm 8599
molybdenum(iv) sulfide, 95.0%
Q424257
56780-54-2
863767-83-3
molybdenite, naturally occurring mineral, grains, approximately 0.06-0.19in
DTXSID201318098
STARBLD0007122
pigment black 34

Research Excerpts

Overview

Molybdenum disulfide (MoS2) is a promising candidate for solar hydrogen generation but it alone has negligible photocatalytic activity. MoS2 is known to be a nonmagnetic material.

ExcerptReferenceRelevance
"Molybdenum disulfide (MoS2) is a promising candidate for solar hydrogen generation but it alone has negligible photocatalytic activity. "( Solar hydrogen generation by nanoscale p-n junction of p-type molybdenum disulfide/n-type nitrogen-doped reduced graphene oxide.
Cushing, SK; Li, J; Meng, F; Wu, N; Zhi, M, 2013
)
2.07
"Bulk molybdenum disulfide is known to be a nonmagnetic material. "( Magnetic molybdenum disulfide nanosheet films.
Ding, J; Loh, KP; Soon, JM; Sullivian, MB; Wu, P; Yin, J; Zhang, J, 2007
)
1.27

Effects

Molybdenum disulfide (MoS2) has attracted increasing research interest recently. Its unique physical, optical and electrical properties are correlated with its 2D ultrathin atomic-layered structure.

ExcerptReferenceRelevance
"Molybdenum disulfide (MoS2) has been developed for medical uses due to its excellent medically beneficial characteristics. "( Functionalised molybdenum disulfide nanosheets for co-delivery of doxorubicin and siRNA for combined chemo/gene/photothermal therapy on multidrug-resistant cancer.
Li, G; Li, X; Liao, C; Lu, T; Meng, F; Nong, Z; Pan, X; Wei, L; Wei, M, 2021
)
2.42
"Molybdenum disulfide (MoS2) has attracted increasing research interest recently due to its unique physical, optical and electrical properties, correlated with its 2D ultrathin atomic-layered structure. "( Seeing diabetes: visual detection of glucose based on the intrinsic peroxidase-like activity of MoS2 nanosheets.
Chen, G; Fu, F; Guo, L; Lin, T; Zhong, L, 2014
)
1.85
"2D molybdenum disulfide (MoS2 ) has distinct optical and electronic properties compared to aggregated MoS2 , enabling wide use of these materials for electronic and biomedical applications. "( Differences in the Toxicological Potential of 2D versus Aggregated Molybdenum Disulfide in the Lung.
Chang, CH; Guiney, LM; Hersam, MC; Ji, Z; Li, R; Liao, YP; Mansukhani, ND; Nel, AE; Song, TB; Sun, B; Wang, M; Wang, X; Xia, T, 2015
)
1.27

Toxicity

ExcerptReferenceRelevance
" Our results indicated that the MoS2 nanosheets synthesized in our work are safe 2D nanosheets for futuristic biomedical applications."( Probing the biocompatibility of MoS2 nanosheets by cytotoxicity assay and electrical impedance spectroscopy.
Alwarappan, S; Li, CZ; Narayanan, TN; Shah, P, 2015
)
0.42
" No adverse effects were observed in birds exposed to MoS2 at the maximum dose of 5000 mg MoS2/kg feed (545 mg MoS2/kg body weight/day)."( Dietary toxicity of soluble and insoluble molybdenum to northern bobwhite quail (Colinus virginianus).
Clark, SL; Engfehr, CL; Fletcher, OJ; Gulde, CM; Lambert, CE; Sample, BE; Stafford, JM; Tiwary, A; Zyskowski, JA, 2016
)
0.43
"Understanding environmental fate is a prerequisite for the safe application of nanoparticles."( Dissolved Oxygen and Visible Light Irradiation Drive the Structural Alterations and Phytotoxicity Mitigation of Single-Layer Molybdenum Disulfide.
Hu, X; Zhang, X; Zhou, Q; Zou, W, 2019
)
0.72
"Understanding the roles of the properties of nanomaterials in biological interactions is a key issue in their safe applications, but the surface atomic arrangement, as an important property of engineered nanomaterials (ENMs), remains largely unknown."( Surface atomic arrangement of nanomaterials affects nanotoxicity.
Hu, X; Li, K; Sun, J; Wang, Y; Wang, Z; Zeng, H; Zhou, Q, 2021
)
0.62
"A safe and efficient platform, α-tocopheryl succinate (α-TOS) married 2D molybdenum disulfide, was devised by a facile method and applied for cooperative imaging-guided photothermal-selective chemotherapy of ovarian carcinoma."( Safe and efficient 2D molybdenum disulfide platform for cooperative imaging-guided photothermal-selective chemotherapy: A preclinical study.
Hu, W; Kong, L; Li, X; Pich, A; Shi, X; Wang, X; Xing, L; Zhang, C, 2022
)
1.27
"3%) of the platform under safe near-infrared irradiation is much higher than that of other photothermal materials reported elsewhere."( Safe and efficient 2D molybdenum disulfide platform for cooperative imaging-guided photothermal-selective chemotherapy: A preclinical study.
Hu, W; Kong, L; Li, X; Pich, A; Shi, X; Wang, X; Xing, L; Zhang, C, 2022
)
1.04
"The safe and efficient platform might be a candidate of clinical nanomedicines for multimode theranostics."( Safe and efficient 2D molybdenum disulfide platform for cooperative imaging-guided photothermal-selective chemotherapy: A preclinical study.
Hu, W; Kong, L; Li, X; Pich, A; Shi, X; Wang, X; Xing, L; Zhang, C, 2022
)
1.04
"Thorough investigations of the environmental fate and risks are necessary for the safe application of engineered nanomaterials."( Mitigation Effects and Associated Mechanisms of Environmentally Relevant Thiols on the Phytotoxicity of Molybdenum Disulfide Nanosheets.
Jiang, K; Jin, C; Zhang, X; Zhao, C; Zhou, Q; Zou, W, 2022
)
0.94
"Although the toxic effects of two-dimensional nanomaterials (2D-NMs) have been widely reported, the influence of extracellular polymeric substances (EPS) on the environmental fate and risk of 2D-NMs in aquatic environments is largely unknown, and the processes and mechanisms involved remain to be revealed."( Extracellular polymeric substances altered the physicochemical properties of molybdenum disulfide nanomaterials to mitigate its toxicity to Chlorella vulgaris.
Cao, M; Chen, H; Sun, K; Wang, F; Yang, D; Yuan, R; Zhou, B, 2023
)
1.14

Bioavailability

ExcerptReferenceRelevance
" The chemical form and bioavailability of Mo is important in determining its toxicity."( Dietary toxicity of soluble and insoluble molybdenum to northern bobwhite quail (Colinus virginianus).
Clark, SL; Engfehr, CL; Fletcher, OJ; Gulde, CM; Lambert, CE; Sample, BE; Stafford, JM; Tiwary, A; Zyskowski, JA, 2016
)
0.43
" However, the frequency of oral administration may result in poor patient compliance, and reduced bioavailability owing to the first-pass effect can also prove problematic."( Poly(Acrylic Acid)-Modified MoS
He, S; Li, J; Liu, X; Zhang, K; Zhuang, Y, 2020
)
0.56

Dosage Studied

ExcerptRelevanceReference
" Inhalation and intratracheal instillation showed similar dose-response relationships for pulmonary and systemic acute phase response when molybdenum disulphide was expressed as dosed surface area."( Comparison of acute phase response in mice after inhalation and intratracheal instillation of molybdenum disulphide and tungsten particles.
Biskos, G; Brostrøm, A; Gutierrez, CT; Hadrup, N; Hafez, I; Loeschner, K; Loizides, C; Møller, P; Roursgaard, M; Saber, AT; Sørli, JB; Vogel, U, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
sulfide saltA salt in which the anionic species is sulfide (S(2-)).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (623)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (0.32)18.2507
2000's16 (2.57)29.6817
2010's422 (67.74)24.3611
2020's183 (29.37)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.50 (24.57)
Research Supply Index6.44 (2.92)
Research Growth Index6.57 (4.65)
Search Engine Demand Index125.69 (26.88)
Search Engine Supply Index3.10 (0.95)

This Compound (51.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews22 (3.53%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other602 (96.47%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]